Science Explorer Back to mapMap

Most cited papers from Centre Hospitalier de Lens

What are the most cited papers from Centre Hospitalier de Lens?

The most cited paper from Centre Hospitalier de Lens is "CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma" (Bertrand Coiffier, Éric Lepage, Josette Brière et al., 2002), with 5,630 citations. Next come "New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment" (1,259) and "Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis" (674).

Showing 50 of 60 papers. Every paper with more than 120 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine Open access 24 Jan 2002 5,630
2 New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment Francisco Cervantes, Brigitte Dupriez, Arturo Pereira et al. · Blood Open access 6 Nov 2008 1,259
3 Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis Christian Pagnoux, Alfred Mahr, Mohamed Amine Hamidou et al. · Yearbook of Medicine 24 Dec 2008 674
4 Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2) Jean Reignier et al. · The Lancet 115 authors 8 Nov 2017 592
5 36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care Open access2,440 authors Apr 2016 531
6 Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment Giovanni Barosi, Ruben A. Mesa, J. Thiele et al. · Leukemia 30 Aug 2007 504
7 A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis Sylvie Naveau, Sylvie Chollet‐Martin, Sébastien Dharancy et al. · Hepatology Open access 26 Apr 2004 447
8 Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study Anahita Rouzé et al. · Intensive Care Medicine Open access 3 Jan 2021 425
9 International prognostic scoring system for Waldenström macroglobulinemia Pierre Morel, Alain Duhamel, Paolo G. Gobbi et al. · Blood Open access 6 Feb 2009 420
10 Comparison of the 5-Hydroxytryptamine 3 (Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced Emesis Michel M. Marty, Pierre Pouillart, Suzy Scholl et al. · New England Journal of Medicine 22 Mar 1990 412
11 Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report Ayalew Tefferi, Francisco Cervantes, Ruben A. Mesa et al. · Blood Open access 9 Jul 2013 385
12 Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects Females Christel Depienne et al. · PLoS Genetics Open access 13 Feb 2009 378
13 ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma Félix M. Reyes, Éric Lepage, Gerard Ganem et al. · New England Journal of Medicine Open access 23 Mar 2005 326
14 Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT) Ruben A. Mesa et al. · Leukemia Research 9 Jan 2007 324
15 Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial Stèphane Gaudry et al. · The Lancet Open access Apr 2021 285
16 Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study Caroline Houillier et al. · Journal of Clinical Oncology 20 Feb 2019 285
17 Response assessment in W aldenström macroglobulinaemia: update from the VI th I nternational W orkshop Roger G. Owen et al. · British Journal of Haematology Open access 15 Nov 2012 279
18 Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3) Jean Reignier et al. · The Lancet Respiratory Medicine Open access161 authors 20 Mar 2023 270
19 Creatine biosynthesis and transport in health and disease Marie Joncquel-Chevalier Curt, Pia‐Manuela Voicu, Monique Fontaine et al. · Biochimie 4 Nov 2015 244
20 Acute myelopathies: Clinical, laboratory and outcome profiles in 79 cases Jerome De Seze · Brain Aug 2001 234
21 Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study Véronique Pierrat, N Haouari, A Liska et al. · Archives of Disease in Childhood Fetal & Neonatal Open access 21 Apr 2005 225
22 Mapping of a second locus for familial hemiplegic migraine to 1q21–q23 and evidence of further heterogeneity Anne Ducros, Anne Joutel, Michaelle Cécillon et al. · Annals of Neurology Dec 1997 222
23 Clinical and genetic studies of Birt-Hogg-Dubé syndrome Sok Kean Khoo, S Giraud, K Kahnoski et al. · Journal of Medical Genetics Open access Dec 2002 218
24 Primary therapy of Waldenström macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN) Meletios Athanasios Dimopoulos, Ramón García‐Sánz, Maria Gavriatopoulou et al. · Blood Open access 5 Sep 2013 211
25 Six-Week Versus Twelve-Week Antibiotic Therapy for Nonsurgically Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study Alina Tone, Sophie Nguyen, Fabrice Devemy et al. · Diabetes Care 20 Nov 2014 210
26 Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial BRIAN A. LAWLOR et al. · PLoS Medicine Open access 24 Sep 2018 207
27 Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial Thierry Thévenot et al. · Journal of Hepatology 21 Nov 2014 199
28 Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM Christian Rosé, Sabine Bréchignac, Dominique Vassilief et al. · Leukemia Research 3 Feb 2010 195
29 Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile Jerome De Seze, Tanya Stojkovic, Didier Ferriby et al. · Journal of the Neurological Sciences May 2002 190
30 Prediction of Early Neurological Deterioration in Individuals With Minor Stroke and Large Vessel Occlusion Intended for Intravenous Thrombolysis Alone Pierre Seners et al. · JAMA Neurology Open access 14 Jan 2021 184
31 Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia Véronique Leblond, Efstathios Kastritis, Ranjana H. Advani et al. · Blood Open access 19 Jul 2016 182
32 Left Ventricular Remodeling After Anterior Wall Acute Myocardial Infarction in Modern Clinical Practice (from the REmodelage VEntriculaire [REVE] Study Group) Christine Savoye, Octave Equine, Olivier Tricot et al. · The American Journal of Cardiology Sep 2006 182
33 Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus Meletios Athanasios Dimopoulos et al. · Blood Open access 16 Jul 2014 169
34 Cerebral venous thrombosis G. Breteau, François Mounier-Vehier, Olivier Godefroy et al. · Journal of Neurology 2003 160
35 Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study Olivier Lucidarme, Elmi Messaï, Thierry Mazzoni et al. · Intensive Care Medicine 7 Apr 2010 155
36 Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia Steven Peter Treon, Andrew Robert Branagan, Leukothea Ioakimidis et al. · Blood Open access 18 Nov 2008 148
37 Update on treatment recommendations from the Third International Workshop on Waldenstrom's Macroglobulinemia Steven Peter Treon · Blood 12 Jan 2006 147
38 Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension Dominique Debray, Panayotis Lykavieris, Frédéric Gauthier et al. · Journal of Hepatology Jul 1999 147
39 Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol Marine Diviné, Philippe Casassus, Serge Koscielny et al. · Annals of Oncology Open access 10 Nov 2005 146
40 Transforming growth factor‐β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis M. C. Martyré, Nicole Romquin, Marie‐Caroline Le Bousse‐Kerdilès et al. · British Journal of Haematology Sep 1994 144
41 Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis M. C. Martyré, Marie‐Caroline Le Bousse‐Kerdilès, Nicole Romquin et al. · British Journal of Haematology Open access May 1997 141
42 Long‐Term Outcomes Among Participants in the WEGENT Trial of Remission‐Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis Xavier Puéchal et al. · Arthritis & Rheumatology Open access 16 Oct 2015 139
43 Understanding negative pressure pulmonary edema Malcolm Lemyze, Jihad Mallat · Intensive Care Medicine Open access 5 May 2014 139
44 Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19 Jean‐Pierre Frat et al. · JAMA Open access 27 Sep 2022 137
45 Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock Jihad Mallat · World Journal of Critical Care Medicine Open access 2016 136
46 Influence of Marital Status and Employment Status on Long-Term Adherence with Continuous Positive Airway Pressure in Sleep Apnea Patients Frédéric Gagnadoux, Marc Le Vaillant, François Goupil et al. · PLoS ONE Open access 17 Aug 2011 135
47 Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III) Arnaud Jaccard, Raymond L. Comenzo, Parameswaran Hari et al. · Haematologica Open access 23 May 2014 135
48 Impact of Type of Preadmission Sulfonylureas on Mortality and Cardiovascular Outcomes in Diabetic Patients with Acute Myocardial Infarction Marianne Zeller, Nicolas Danchin, Dominique Simon et al. · The Journal of Clinical Endocrinology & Metabolism 12 Aug 2010 134
49 patients with the description of a new scoring system and its validation on 253 other patients. Pierre Morel, Mathieu Monconduit, Dominique Jacomy et al. · PubMed Aug 2000 134
50 Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: a multicenter retrospective study in 188 patients in an un-inundated French region Gauthier Blonz, Achille Kouatchet, Nicolas Chudeau et al. · Critical Care Open access 18 Feb 2021 133

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.